[go: up one dir, main page]

DK0455725T3 - Farmaceutiske præparater med plasminogenaktivatorproteiner - Google Patents

Farmaceutiske præparater med plasminogenaktivatorproteiner

Info

Publication number
DK0455725T3
DK0455725T3 DK90903109.8T DK90903109T DK0455725T3 DK 0455725 T3 DK0455725 T3 DK 0455725T3 DK 90903109 T DK90903109 T DK 90903109T DK 0455725 T3 DK0455725 T3 DK 0455725T3
Authority
DK
Denmark
Prior art keywords
pharmaceuticals
plasminogen activator
activator proteins
proteins
excipients
Prior art date
Application number
DK90903109.8T
Other languages
Danish (da)
English (en)
Inventor
Benjamin S Isaacs
Himakshi Patel
Original Assignee
Genetics Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Inst filed Critical Genetics Inst
Application granted granted Critical
Publication of DK0455725T3 publication Critical patent/DK0455725T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DK90903109.8T 1989-01-27 1990-01-26 Farmaceutiske præparater med plasminogenaktivatorproteiner DK0455725T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/302,846 US4980165A (en) 1989-01-27 1989-01-27 Pharmaceutical formulations of plasminogen activator proteins

Publications (1)

Publication Number Publication Date
DK0455725T3 true DK0455725T3 (da) 1994-09-05

Family

ID=23169461

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90903109.8T DK0455725T3 (da) 1989-01-27 1990-01-26 Farmaceutiske præparater med plasminogenaktivatorproteiner

Country Status (9)

Country Link
US (1) US4980165A (fr)
EP (1) EP0455725B1 (fr)
JP (1) JP2636499B2 (fr)
AT (1) ATE104863T1 (fr)
CA (1) CA2045562A1 (fr)
DE (1) DE69008513T2 (fr)
DK (1) DK0455725T3 (fr)
ES (1) ES2055902T3 (fr)
WO (1) WO1990008557A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270198A (en) * 1988-05-20 1993-12-14 Genentech, Inc. DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells
US5714145A (en) * 1988-09-02 1998-02-03 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US5262170A (en) * 1988-09-02 1993-11-16 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells
JP2520975B2 (ja) * 1989-09-21 1996-07-31 三井東圧化学株式会社 組織プラスミノ―ゲンアクチベ―タ―若しくはその誘導体を含有する血栓溶解剤
DE3942143A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh T-pa pro stabilisierung
DE3942145A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh T-pa-solubilisierung
DE3942141A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh K2p pro-stabilisierung
DE3942142A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh Stabilisierung von glykosyliertem t-pa
US5366730A (en) * 1989-12-20 1994-11-22 Boehringer Mannheim Gmbh Stabilized compositions having human tissue type plasminogen activator enzymatic activity
CA2107476C (fr) * 1991-04-16 2007-12-18 Martin Ulrich Unite d'emballage pharmaceutique contenant des activateurs du plasminogene pour administrations multiples en bolus
DK0786257T3 (da) * 1992-06-03 2003-10-06 Genentech Inc Glycolyseringsvarianter af vævsplasminogenaktivator med forbedrede terapeutiske egenskaber
US5510330A (en) * 1994-03-25 1996-04-23 Boehringer Mannheim Gmbh Combinations of thrombolytically active proteins and non-heparin anticoagulants, and uses thereof.
KR100236393B1 (ko) 1996-02-02 1999-12-15 나까니시 히로유끼 사람성장호르몬을 함유하는 의약제제
JP5325779B2 (ja) 2007-06-14 2013-10-23 株式会社ポーラファルマ 医薬組成物
DE102007057543A1 (de) * 2007-11-29 2009-06-04 Merck Patent Gmbh a-Aminosäurederivate zur Löslichkeitsverbesserung
WO2010059232A1 (fr) 2008-11-20 2010-05-27 Biogen Idec Ma Inc. Inactivation de virus par l’arginine
ES2899756T3 (es) * 2013-03-12 2022-03-14 Primal Therapies Inc Composición dental que comprende quelante y base

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54147916A (en) * 1978-05-12 1979-11-19 Sumitomo Chem Co Ltd Preparation of urokinase injection
DE3203775A1 (de) * 1982-02-04 1983-08-11 Behringwerke Ag, 3550 Marburg Fibrinogenzubereitung, verfahen zu ihrer herstellungund ihre verwendung
JPS5951220A (ja) * 1982-08-02 1984-03-24 Asahi Chem Ind Co Ltd 新規なプラスミノ−ゲン・アクチベ−タ−およびその製法ならびにこれを含有する薬剤
US4929444A (en) * 1985-05-28 1990-05-29 Burroughs Wellcome Co. Low pH pharmaceutical formulation containing t-PA
AT391812B (de) * 1985-05-28 1990-12-10 Wellcome Found Verfahren zur herstellung einer parenteralen t-pa-loesung
ZW14486A1 (en) * 1985-07-29 1986-10-22 Smithkline Beckman Corp Pharmaceutical dosage unit
EP0238551A4 (fr) * 1985-09-06 1988-02-01 Codon Procedes de recuperation d'un activateur de plasminogene des tissus.
JPH0672105B2 (ja) * 1985-10-02 1994-09-14 持田製薬株式会社 血栓溶解剤及びその製法
US4777043A (en) * 1985-12-17 1988-10-11 Genentech, Inc. Stabilized human tissue plasminogen activator compositions
US4857320A (en) * 1987-02-19 1989-08-15 Monsanto Company Method of enhancing the solubility of tissue plasminogen activator
DE3718889A1 (de) * 1987-06-05 1988-12-22 Behringwerke Ag Verfahren zur herstellung einer loesung hoher spezifischer volumenaktivitaet von einem protein mit gewebe-plasminogenaktivator (t-pa)-aktivitaet, loesung, enthaltend protein mit t-pa-aktivitaet und verwendung der loesung in der human- und veterinaermedizin
JP2708749B2 (ja) * 1987-08-10 1998-02-04 エーザイ株式会社 修飾型ｔＰＡ含有注射用組成物
US4898826A (en) * 1987-12-10 1990-02-06 Invitron Corporation Method to solubilize tissue plasminogen activator

Also Published As

Publication number Publication date
WO1990008557A1 (fr) 1990-08-09
DE69008513D1 (de) 1994-06-01
US4980165A (en) 1990-12-25
EP0455725A1 (fr) 1991-11-13
ES2055902T3 (es) 1994-09-01
DE69008513T2 (de) 1994-11-24
ATE104863T1 (de) 1994-05-15
EP0455725B1 (fr) 1994-04-27
CA2045562A1 (fr) 1990-07-28
JPH04503070A (ja) 1992-06-04
JP2636499B2 (ja) 1997-07-30

Similar Documents

Publication Publication Date Title
DK0455725T3 (da) Farmaceutiske præparater med plasminogenaktivatorproteiner
EA200200017A1 (ru) Терапевтическое средство с ботулиническим нейротоксином
CA1340270C (fr) Composition thrombolytique et methode de preparation
ATE279430T1 (de) Verfahren zur verbesserung der serum halbwertszeit von biologisch aktiven molekülen
BR9507189A (pt) Combinaçoes de proteinas tromboliticamente ativas e anticoagulantes e usos dos mesmos
DE60038104D1 (de) Arzneimittelzubereitungen für die behandlung von alpha-galactosidase a-mangel
SE8402560L (sv) Farmaceutisk komposition
FI945198A0 (fi) Farmaseuttiset ja muut annosmuodot
ES2130162T3 (es) Formas topicas de alta dosificacion de colagenasa.
DK1233784T3 (da) Præparater og fremgangsmåder til stabilisering af biologiske molekyler efter lyofilisering
DK0710228T3 (da) Hydraziner med N3S-konfiguration som radionuclidchelatorer
SE8504945L (sv) Farmaceutiska kompositioner innehallande antracyklinglykosider
EP0714435A4 (fr) Pro-urokinases obtenues par mutation
DK304288D0 (da) Fremgangsmaade til fremstilling af en oploesning med hoej specifik rumgangsaktivitet af et protein med vaevs-plasmino-genaktivator (t-pa)-aktivitet og anvendelse af en oploesning, der indeholder protein med t-pa-aktivitet
DE69434384D1 (de) Metalkomplexbildner
FI953565A7 (fi) Uusi antikoagulanttikofaktoriaktiivisuus
ES2053658T3 (es) Agente trombolitico.
ATE126063T1 (de) Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen.
IT1249650B (it) N-(5-tioxo-l-prolil)-l-cisteina e suoi derivati, loro preparazione ed impiego terapeutico
ES2033295T3 (es) Un metodo para preparar un activador de plasminogeno.
ATE137487T1 (de) Komplexe, enthaltend s(+)-phenyl-alkansäuren und alpha-hydroxy-alkansäuren
ES2067221T3 (es) Activador de plasminogeno del tejido que tiene propiedades especificas para la fibrina.
ATE127839T1 (de) Varianten des gewebeplasminogenaktivators mit vermindertem abbau.
PT83721B (pt) Processo de preparacao de composicoes farmaceuticas a base de activadores de plasminogenio com actividade trombolitica
DK0381640T3 (da) Thrombolytiske præparater